ARDELYX INC
For the period ended Sep 30, 2024. Filed Oct 31, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Oct 31, 2024
ARDX$3.01+2.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Statements of Operations and Comprehensive Income (Loss (unaudited)
CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
(in thousands, except share and per share amounts)
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Revenues: | ||||
| Product sales, net | $92,090 | $22,285 | $208,193 | $51,949 |
| Product supply revenue | 5,322 | 2,092 | 7,461 | 5,354 |
| Licensing revenue | 20 | 32,014 | 56 | 32,790 |
| Non-cash royalty revenue related to the sale of future royalties | 809 | — | 1,776 | — |
| Total revenues | 98,241 | 56,391 | 217,486 | 90,093 |
| Cost of goods sold: | ||||
| Cost of product sales | 1,715 | 644 | 4,133 | 1,508 |
| Other cost of revenue | 14,013 | 7,048 | 28,159 | 11,210 |
| Total cost of goods sold | 15,728 | 7,692 | 32,292 | 12,718 |
| Operating expenses: | ||||
| Research and development | 15,310 | 8,637 | 38,651 | 26,012 |
| Selling, general and administrative | 64,970 | 32,664 | 182,618 | 86,653 |
| Total operating expenses | 80,280 | 41,301 | 221,269 | 112,665 |
| Income (loss) from operations | 2,233 | 7,398 | (36,075) | (35,290) |
| Interest expense | (3,357) | (1,107) | (9,039) | (3,210) |
| Non-cash interest expense related to the sale of future royalties | (1,924) | (922) | (5,202) | (2,859) |
| Other income, net | 2,282 | 1,460 | 6,766 | 4,308 |
| Income (loss) before provision for income taxes | (766) | 6,829 | (43,550) | (37,051) |
| Provision for income taxes | 43 | 200 | 231 | 214 |
| Net income (loss) | $(809) | $6,629 | $(43,781) | $(37,265) |
| Net income (loss) per share of common stock - basic and diluted | $(0.00) | $0.03 | $(0.19) | $(0.17) |
| Shares used in computing net income (loss) per share - basic | 235,911,399 | 222,782,229 | 234,516,305 | 214,976,555 |
| Shares used in computing net income (loss) per share - diluted | 235,911,399 | 227,894,335 | 234,516,305 | 214,976,555 |
| Comprehensive income (loss): | ||||
| Net income (loss) | $(809) | $6,629 | $(43,781) | $(37,265) |
| Unrealized gains (losses) on available-for-sale securities | 286 | 9 | (39) | (147) |
| Comprehensive income (loss) | $(523) | $6,638 | $(43,820) | $(37,412) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.